scholarly journals Cognitive stimulation therapy for people with dementia in Brazil (CST‐Brasil): Results from a single blind randomized controlled trial

2020 ◽  
Author(s):  
Valeska Marinho ◽  
Elodie Bertrand ◽  
Renata Naylor ◽  
Iris Bomilcar ◽  
Jerson Laks ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Cognitive Stimulation ◽  
Randomized Controlled ◽  
Cognitive Stimulation Therapy ◽  
People With Dementia ◽  
Single Blind

scholarly journals Individual Cognitive Stimulation Therapy in Alzheimer’s Disease: A Randomized Controlled Trial

2021 ◽  
Author(s):  
Yu-chen Qiao ◽  
Hong Chang ◽  
Rui Wang ◽  
Jia-Mei Wang ◽  
Xiao-ying Wang ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Intervention Group ◽  
Cognitive Stimulation ◽  
Control Group ◽  
Randomized Controlled ◽  
Cognitive Stimulation Therapy ◽  
Individual Cognitive Stimulation Therapy

Abstract Background: Individual cognitive stimulation therapy (ICST) can benefit cognition and quality of life for people with dementia, but the evidence for nurses-led individual cognitive stimulation interventions is limited.Objectives: The current study aimed to develop the process of planning and implementing ICST, and evaluate the effect of ICST on cognitive function and therapeutic effect in patients with mild Alzheimer’s disease (AD). Methods: It was a randomized controlled trial lasting for a half year. 38 patients with mild AD were recruited. The control group was given the “Individual Cognitive Stimulation Therapy Manual for AD” to deliver the sessions at home. The intervention group was given 90 minutes ‘cognitive stimulation sessions, completed up to three times weekly over 24 weeks. The outcomes were measured at baseline and 24weeks by the scales widely used in AD evaluation (MMSE, MoCA and ADL).Results: There were statistical significance between the two groups, especially the scores of memory, delayed memory in MMSE and scores of memory, delayed memory, immediate memory, attention in MoCA were significantly improved in the intervention group compared with control group. ICST show positive effects that may help preserve memory in mild AD.Conclusions: The ICST can improve the memory and attention cognitive domains in patients with mild AD. And the feedback from patient and caregiver in ICST was favorable.

scholarly journals The quest for synergy between physical exercise and cognitive stimulation via exergaming in people with dementia: a randomized controlled trial

2019 ◽  
Vol 11 (1) ◽  
Author(s):  
Esther G. A. Karssemeijer ◽  
Justine A. Aaronson ◽  
Willem J. R. Bossers ◽  
Rogier Donders ◽  
Marcel G. M. Olde Rikkert ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Physical Exercise ◽  
Controlled Trial ◽  
Cognitive Stimulation ◽  
Randomized Controlled ◽  
People With Dementia

scholarly journals Maintenance cognitive stimulation therapy for dementia: single-blind, multicentre, pragmatic randomised controlled trial

2014 ◽  
Vol 204 (6) ◽  
pp. 454-461 ◽  
Author(s):  
Martin Orrell ◽  
Elisa Aguirre ◽  
Aimee Spector ◽  
Zoe Hoare ◽  
Robert T. Woods ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Controlled Trial ◽  
Intervention Group ◽  
Cognitive Stimulation ◽  
Cognitive Stimulation Therapy ◽  
People With Dementia ◽  
Randomised Controlled ◽  
Single Blind ◽  
Pragmatic Randomised Controlled Trial

BackgroundThere is good evidence for the benefits of short-term cognitive stimulation therapy for dementia but little is known about possible long-term effects.AimsTo evaluate the effectiveness of maintenance cognitive stimulation therapy (CST) for people with dementia in a single-blind, pragmatic randomised controlled trial including a substudy with participants taking acetylcholinesterase inhibitors (AChEIs).MethodThe participants were 236 people with dementia from 9 care homes and 9 community services. Prior to randomisation all participants received the 7-week, 14-session CST programme. The intervention group received the weekly maintenance CST group programme for 24 weeks. The control group received usual care. Primary outcomes were cognition and quality of life (clinical trial registration: ISRCTN26286067).ResultsFor the intervention group at the 6-month primary end-point there were significant benefits for self-rated quality of life (Quality of Life in Alzheimer's Disease (QoL-AD) P = 0.03). At 3 months there were improvements for proxy-rated quality of life (QoL-AD P = 0.01, Dementia Quality of Life scale (DEMQOL) P = 0.03) and activities of daily living (P = 0.04). The intervention subgroup taking AChEIs showed cognitive benefits (on the Mini-Mental State Examination) at 3 (P = 0.03) and 6 months (P = 0.03).ConclusionsContinuing CST improves quality of life; and improves cognition for those taking AChEIs.

Sign in / Sign up

Export Citation Format

Share Document